Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders

SM Stanford, N Bottini - Nature Reviews Drug Discovery, 2023 - nature.com
Protein phosphatases act as key regulators of multiple important cellular processes and are
attractive therapeutic targets for various diseases. Although extensive effort has been …

Protein tyrosine phosphatases as potential regulators of STAT3 signaling

M Kim, LD Morales, IS Jang, YY Cho… - International journal of …, 2018 - mdpi.com
The signal transducer and activator of transcription 3 (STAT3) protein is a major transcription
factor involved in many cellular processes, such as cell growth and proliferation …

Oral metal‐free melanin nanozymes for natural and durable targeted treatment of inflammatory bowel disease (IBD)

Q Huang, Y Yang, Y Zhu, Q Chen, T Zhao, Z **ao… - Small, 2023 - Wiley Online Library
Oral antioxidant nanozymes bring great promise for inflammatory bowel disease (IBD)
treatment. To efficiently eliminate reactive oxygen species (ROS), various metal‐based …

Long non-coding RNAs and their “discrete” contribution to IBD and Johne's disease—what stands out in the current picture? A comprehensive review

KA Triantaphyllopoulos - International Journal of Molecular Sciences, 2023 - mdpi.com
Non-coding RNAs (ncRNA) have paved the way to new perspectives on the regulation of
gene expression, not only in biology and medicine, but also in associated fields and …

The catalytic activity of TCPTP is auto-regulated by its intrinsically disordered tail and activated by Integrin alpha-1

JP Singh, Y Li, YY Chen, STD Hsu, R Page… - Nature …, 2022 - nature.com
Abstract T-Cell Protein Tyrosine Phosphatase (TCPTP, PTPN2) is a non-receptor type
protein tyrosine phosphatase that is ubiquitously expressed in human cells. TCPTP is a …

Reduced expression of phosphatase PTPN2 promotes pathogenic conversion of Tregs in autoimmunity

MND Svensson, KM Doody… - The Journal of …, 2019 - Am Soc Clin Investig
Genetic variants at the PTPN2 locus, which encodes the tyrosine phosphatase PTPN2,
cause reduced gene expression and are linked to rheumatoid arthritis (RA) and other …

Crystal structure of TCPTP unravels an allosteric regulatory role of helix α7 in phosphatase activity

JP Singh, MJ Lin, SF Hsu, W Peti, CC Lee… - Biochemistry, 2021 - ACS Publications
The T-cell protein tyrosine phosphatase (TCPTP/PTPN2) targets a broad variety of
substrates across different subcellular compartments. In spite of that, the structural basis for …

TRIM18-Regulated STAT3 Signaling Pathway via PTP1B Promotes Renal Epithelial–Mesenchymal Transition, Inflammation, and Fibrosis in Diabetic Kidney Disease

Q Chen, C Gao, M Wang, X Fei, N Zhao - Frontiers in Physiology, 2021 - frontiersin.org
Diabetic kidney disease (DKD) has become a key cause of end-stage renal disease
worldwide. Inflammation and fibrosis have been shown to play important roles in the …

[HTML][HTML] PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis

WC Hsieh, MND Svensson, M Zoccheddu… - JCI insight, 2020 - ncbi.nlm.nih.gov
Loss-of-function variants of protein tyrosine phosphatase non-receptor type 2 (PTPN2)
enhance risk of inflammatory bowel disease and rheumatoid arthritis; however, whether the …

[HTML][HTML] SRC-3 protects intestine from DSS-induced colitis by inhibiting inflammation and promoting goblet cell differentiation through enhancement of KLF4 …

W Chen, M Zhuo, X Lu, X **a, Y Zhao… - … Journal of Biological …, 2018 - ncbi.nlm.nih.gov
Goblet cell loss, which leads to the reduction of mucin secretion, is a hallmark of ulcerative
colitis (UC). We previously reported that steroid receptor coactivator 3 (SRC-3), a …